Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Explore options for retirement accounts at 50. Make informed choices to secure your financial future.
24,046 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
The Nasdaq Composite climbed again as semiconductors rebound and AI-driven demand steadies, signaling a renewed risk-...
As the Fed signals potential slower rate moves, tech stocks gyrate. The standout is a cash-generating giant deliverin...
When a network equipment company taps the market for capital, a stock pullback often follows. Here’s a clear, investo...
U.S. equities sit near record highs as AI spending fuels gains, but a growing chorus on Wall Street warns that federa...
Broadcom faced a sharp earnings-driven selloff, tumbling about 14% in a single day. This article spotlights an under-...
Alphabet stands out as a durable cash engine blending a near-monopoly ad business with AI-driven cloud gains, offerin...
Bitcoin dipped toward the $61,000 mark as XRP and ADA fell sharply, signaling renewed risk-off in crypto markets. The...
A single Magnificent 7 stock is proving steadier than peers as AI demand drives earnings and share gains, challenging...
Ethereum appears to hold a clearer path for near-term traders, while Ripple’s XRP may deliver stronger gains for thos...
A top Wall Street CIO says the AI trade is overheating and chart signals warn of a pullback. He urges shifting into e...
Chevron’s finance chief Eimear Bonner outlines how finance leaders are shaping AI value at the oil giant, turning tec...